abstract |
COMPOUND, USE OF A COMPOUND, AND PHARMACEUTICAL COMPOSITION. The invention relates to compounds of formula (I), wherein the variables are as defined in the claims. The compounds are prodrugs of A2A-receptor ligands, with improved aqueous solubility, and are useful in the treatment of neurological and psychiatric disorders, in which the A2A receptor is implicated. |